Table 1 .
The pooled perioperative and long-term outcomes after combined heart and liver transplantation
| Pooled value | 95% CI | Number of studies | Heterogeneity (I 2 ) | p-value | |
|---|---|---|---|---|---|
| Operative outcomes | |||||
| Cardiopulmonary bypass duration (min) | 183.5 | 142.9–224.2 | 6 | 93.4% | <0.1 |
| RBC transfusion (units) | 17.9 | 7.7–28.1 | 4 | 98.4% | <0.1 |
| FFP transfusion (units) | 14.3 | 6.1–22.6 | 3 | 89.1% | <0.1 |
| ICU stay (days) | 9.9 | 7.5–12.2 | 6 | 46.9% | <0.1 |
| Postoperative infection | 20.8% | 6.8–40.1% | 8 | 90.2% | <0.0001 |
| Mechanical ventilation | 66.5% | 28.1–95.1% | 8 | 98.7% | <0.0001 |
| Survival outcomes | |||||
| Hospital stay (days) | 25.8 | 21.2–30.4 | 7 | 32.2% | 0.2 |
| Mortality rate | 14.1% | 8.3–21.1% | 13 | 78.6% | <0.0001 |
| 1-year survival rate | 85.3% | 80.3–89.6% | 11 | 65.7% | 0.0012 |
| 5-year survival rate | 71.4% | 57.9%–83.1% | 12 | 94.2% | <0.0001 |
| Follow-up duration (months) | 56.8 | 31.5–82.1 | 16 | 100% | <0.1 |
| Heart rejection rate | 6.1% | 1.6–13.1% | 12 | 78.2% | <0.0001 |
| Liver rejection rate | 9.1% | 3.1–18.1% | 12 | 81.6% | <0.0001 |
CI = confidence interval; FFP = fresh frozen plasma; ICU = intensive care unit; RBC = red blood cell